Denice Torres
CIK 1820278 · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.18M
Companies
7
Total Filings
31
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLDX | Director | — | $37.35 | — | $0 | 2 | 2026-06-29 |
| GKOS | Director | 24,212 | $161.75 | $3.92M | $0 | 12 | 2026-06-23 |
| SPTX | Director | 13,406 | $19.64 | $263.2K | $0 | 1 | 2026-05-04 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 31,560 | $5.00 | $157.8K | $0 | 4 | 2024-06-12 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $0 | 5 | 2024-03-18 |
| Surface Oncology, Inc. (SURF) Delisted | Director | — | $1.07 | — | $0 | 3 | 2022-06-10 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 136 | $4.97 | $676 | $0 | 3 | 2021-11-17 |
Recent Filings · Page 2 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −990 | -$326.7K | EDGAR |
| 2024-01-04 | GKOS | Grant (A) | +895 | $0 | EDGAR |
| 2023-06-22 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | +990 | $0 | EDGAR |
| 2023-06-15 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +8,400 | $0 | EDGAR |
| 2023-06-05 | GKOS | Grant (A) | +3,230 | $0 | EDGAR |
| 2023-01-04 | GKOS | Grant (A) | +1,572 | $0 | EDGAR |
| 2022-06-16 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +8,200 | $0 | EDGAR |
| 2022-06-06 | GKOS | Grant (A) | +4,364 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.